0907 ET - Investors have been shying away from Jamieson Wellness as they look for the safer haven of larger cap companies, but TD Cowen's Derek Lessard thinks the pullback is unwarranted. So far in the year, the stock has pulled back 15% to C$31.11, nearly wiping out the gains of the past 52 weeks. But there are plenty of positives to drive the stock, including strong contributions from the Chinese market. "With no negative operational news, our positive outlook on 4Q and longer-term is unchanged," he says in a report. The fundamentals are the same, and with the stock down, it "makes the pullback an attractive buying opportunity." (adriano.marchese@wsj.com)
(END) Dow Jones Newswires
February 10, 2025 09:07 ET (14:07 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。